Premium
Serum alkylresorcinols as biomarkers of dietary gluten exposure in coeliac disease
Author(s) -
Choung R. S.,
Murray J. A.,
Marietta E. V.,
Van Dyke C. T.,
Ross A. B.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13917
Subject(s) - coeliac disease , gluten free , medicine , gluten , gastroenterology , endocrinology , disease , pathology
Summary Background Therapy for coeliac disease ( CD ) mainly relies on following a gluten‐free diet ( GFD ); however, a serum marker for gluten intake has yet to be established. Aim To evaluate the utility of alkylresorcinol concentrations for detecting gluten intake in studies of human and mouse. Methods Alkylresorcinol concentrations were compared among treated patients with coeliac disease ( n = 34), untreated coeliac disease patients ( n = 36) and controls ( n = 33). Furthermore, seven additional coeliac disease patients whose serum samples were available at diagnosis and after GFD were evaluated. In mice studies, alkylresorcinol concentrations were compared in the serum of five mice fed a regular chow and 10 mice fed lifelong with a gluten‐free chow. In addition, the effect of adding gluten on changes of alkylresorcinol concentrations was also evaluated. Results Total alkylresorcinol concentrations were significantly lower in treated with coeliac disease [median ( IQR ), 3 (2–8) nmol/L], compared to untreated patients [median ( IQR ), 32 (11–74) nmol/L; P < 0.0001] or healthy controls [median ( IQR ), 54 (23–112) nmol/L; P < 0.0001]. Moreover, alkylresorcinol concentrations in coeliac disease patients significantly decreased after introduction of a GFD (median, 34 nmol/L at diagnosis vs. 5 nmol/L after GFD , P = 0.02). In the mice, median ( IQR ) total alkylresorcinol concentrations in serum samples of mice fed lifelong with a gluten‐free chow was 1.8 (1.6–2.3) nmol/L, which was further significantly increased to 16 (11–22) nmol/L after 8 days of feeding with the gluten‐free chow that had gluten added to it. ( P = 0.008). Conclusion Serum alkylresorcinol concentrations could be a useful marker for dietary gluten in coeliac disease.